Annual EBITDA
-$9.40 M
+$794.10 K+7.79%
December 31, 2023
Summary
- As of February 7, 2025, KRMD annual EBITDA is -$9.40 million, with the most recent change of +$794.10 thousand (+7.79%) on December 31, 2023.
- During the last 3 years, KRMD annual EBITDA has fallen by -$11.01 million (-683.46%).
- KRMD annual EBITDA is now -316.50% below its all-time high of $4.34 million, reached on December 31, 2019.
Performance
KRMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.48 M
-$501.30 K-51.46%
September 30, 2024
Summary
- As of February 7, 2025, KRMD quarterly EBITDA is -$1.48 million, with the most recent change of -$501.30 thousand (-51.46%) on September 30, 2024.
- Over the past year, KRMD quarterly EBITDA has increased by +$493.70 thousand (+25.07%).
- KRMD quarterly EBITDA is now -183.30% below its all-time high of $1.77 million, reached on September 30, 2019.
Performance
KRMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$6.15 M
+$99.50 K+1.59%
September 30, 2024
Summary
- As of February 7, 2025, KRMD TTM EBITDA is -$6.15 million, with the most recent change of +$99.50 thousand (+1.59%) on September 30, 2024.
- Over the past year, KRMD TTM EBITDA has increased by +$3.25 million (+34.58%).
- KRMD TTM EBITDA is now -235.13% below its all-time high of $4.55 million, reached on March 31, 2020.
Performance
KRMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KRMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | +25.1% | +34.6% |
| 3 y3 years | -683.5% | -22.3% | -9.6% |
| 5 y5 years | -496.1% | -183.3% | -241.6% |
KRMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.1% | +7.8% | -51.5% | +57.7% | at high | +39.7% |
| 5 y | 5-year | -316.5% | +7.8% | -271.1% | +57.7% | -235.1% | +39.7% |
| alltime | all time | -316.5% | +7.8% | -183.3% | +57.7% | -235.1% | +39.7% |
KORU Medical Systems EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.48 M(+51.5%) | -$6.15 M(-1.6%) |
| Jun 2024 | - | -$974.20 K(-43.7%) | -$6.25 M(-24.6%) |
| Mar 2024 | - | -$1.73 M(-12.1%) | -$8.29 M(-11.8%) |
| Dec 2023 | -$9.40 M(-7.8%) | -$1.97 M(+25.0%) | -$9.40 M(-3.6%) |
| Sep 2023 | - | -$1.57 M(-47.7%) | -$9.75 M(+2.2%) |
| Jun 2023 | - | -$3.01 M(+5.9%) | -$9.54 M(-4.7%) |
| Mar 2023 | - | -$2.84 M(+22.4%) | -$10.02 M(-1.7%) |
| Dec 2022 | -$10.19 M(+55.2%) | -$2.32 M(+70.2%) | -$10.19 M(+3.3%) |
| Sep 2022 | - | -$1.37 M(-60.9%) | -$9.87 M(+1.6%) |
| Jun 2022 | - | -$3.49 M(+15.6%) | -$9.71 M(+29.7%) |
| Mar 2022 | - | -$3.02 M(+50.9%) | -$7.49 M(+14.0%) |
| Dec 2021 | -$6.57 M(-507.6%) | -$2.00 M(+65.8%) | -$6.57 M(+17.1%) |
| Sep 2021 | - | -$1.21 M(-4.5%) | -$5.61 M(+42.8%) |
| Jun 2021 | - | -$1.26 M(-39.8%) | -$3.93 M(+8.8%) |
| Mar 2021 | - | -$2.10 M(+101.1%) | -$3.61 M(+328.2%) |
| Dec 2020 | $1.61 M(-62.9%) | -$1.04 M(-319.6%) | -$843.30 K(-179.4%) |
| Sep 2020 | - | $475.10 K(-150.3%) | $1.06 M(-55.0%) |
| Jun 2020 | - | -$945.20 K(-241.1%) | $2.36 M(-48.2%) |
| Mar 2020 | - | $670.00 K(-22.3%) | $4.55 M(+4.8%) |
| Dec 2019 | $4.34 M(+83.0%) | $862.20 K(-51.3%) | $4.34 M(+26.6%) |
| Sep 2019 | - | $1.77 M(+42.0%) | $3.43 M(+36.9%) |
| Jun 2019 | - | $1.25 M(+170.4%) | $2.51 M(+28.4%) |
| Mar 2019 | - | $461.10 K(-1027.8%) | $1.95 M(-5.5%) |
| Dec 2018 | $2.37 M(+58.8%) | -$49.70 K(-105.9%) | $2.07 M(-2.3%) |
| Sep 2018 | - | $847.50 K(+22.3%) | $2.12 M(+21.7%) |
| Jun 2018 | - | $693.00 K(+20.4%) | $1.74 M(+32.4%) |
| Mar 2018 | - | $575.70 K(+22.5%) | $1.31 M(+120.0%) |
| Dec 2017 | $1.49 M(-415.0%) | - | - |
| Sep 2017 | - | $469.90 K(+75.9%) | $596.70 K(+632.1%) |
| Jun 2017 | - | $267.10 K(-492.8%) | $81.50 K(-116.8%) |
| Feb 2017 | - | -$68.00 K(-5.9%) | -$485.00 K(-469.4%) |
| Feb 2017 | -$474.20 K(-133.5%) | - | - |
| Nov 2016 | - | -$72.30 K(+59.6%) | $131.30 K(-75.1%) |
| Aug 2016 | - | -$45.30 K(-84.9%) | $527.10 K(-54.1%) |
| May 2016 | - | -$299.40 K(-154.6%) | $1.15 M(-19.9%) |
| Feb 2016 | $1.42 M(+4.3%) | $548.30 K(+69.5%) | $1.43 M(+4.1%) |
| Nov 2015 | - | $323.50 K(-43.9%) | $1.38 M(+11.3%) |
| Aug 2015 | - | $576.90 K(-4191.5%) | $1.24 M(+18.9%) |
| May 2015 | - | -$14.10 K(-102.9%) | $1.04 M(-23.2%) |
| Feb 2015 | $1.36 M(+8.9%) | $491.20 K(+167.5%) | $1.36 M(-6.0%) |
| Nov 2014 | - | $183.60 K(-51.7%) | $1.44 M(-7.7%) |
| Aug 2014 | - | $380.20 K(+26.4%) | $1.56 M(+13.4%) |
| May 2014 | - | $300.80 K(-47.9%) | $1.38 M(+10.4%) |
| Feb 2014 | $1.25 M(-0.7%) | $577.60 K(+90.2%) | $1.25 M(+22.7%) |
| Nov 2013 | - | $303.70 K(+55.3%) | $1.02 M(+18.8%) |
| Aug 2013 | - | $195.60 K(+14.4%) | $856.00 K(-31.1%) |
| May 2013 | - | $171.00 K(-50.6%) | $1.24 M(-1.1%) |
| Feb 2013 | $1.26 M | $346.50 K(+142.5%) | $1.26 M(-9.2%) |
| Nov 2012 | - | $142.90 K(-75.5%) | $1.38 M(-12.7%) |
| Aug 2012 | - | $582.60 K(+214.2%) | $1.59 M(+28.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2012 | - | $185.40 K(-60.8%) | $1.23 M(-13.0%) |
| Feb 2012 | $1.42 M(+9.4%) | $473.20 K(+37.3%) | $1.42 M(-8.9%) |
| Nov 2011 | - | $344.70 K(+50.5%) | $1.56 M(+2.3%) |
| Aug 2011 | - | $229.10 K(-38.0%) | $1.52 M(+2.2%) |
| May 2011 | - | $369.60 K(-39.6%) | $1.49 M(+14.9%) |
| Feb 2011 | $1.30 M(+67.2%) | $612.10 K(+97.5%) | $1.30 M(+28.3%) |
| Nov 2010 | - | $309.90 K(+58.0%) | $1.01 M(+22.6%) |
| Aug 2010 | - | $196.20 K(+10.8%) | $823.50 K(-1.5%) |
| May 2010 | - | $177.10 K(-45.8%) | $835.70 K(+7.9%) |
| Feb 2010 | $774.80 K(-9.5%) | $326.50 K(+163.9%) | $774.80 K(+15.7%) |
| Nov 2009 | - | $123.70 K(-40.6%) | $669.90 K(-12.5%) |
| Aug 2009 | - | $208.40 K(+79.3%) | $765.80 K(-12.7%) |
| May 2009 | - | $116.20 K(-47.6%) | $877.60 K(+2.5%) |
| Feb 2009 | $855.90 K(+227.1%) | $221.60 K(+0.9%) | $855.90 K(+7.8%) |
| Nov 2008 | - | $219.60 K(-31.4%) | $793.70 K(+18.3%) |
| Aug 2008 | - | $320.20 K(+238.8%) | $671.10 K(+53.7%) |
| May 2008 | - | $94.50 K(-40.7%) | $436.70 K(+64.9%) |
| Feb 2008 | $261.70 K(+583.3%) | $159.40 K(+64.3%) | $264.80 K(+61.1%) |
| Nov 2007 | - | $97.00 K(+13.1%) | $164.40 K(+49.9%) |
| Aug 2007 | - | $85.80 K(-210.9%) | $109.70 K(+84.4%) |
| May 2007 | - | -$77.40 K(-231.2%) | $59.50 K(+55.4%) |
| Feb 2007 | $38.30 K(-516.3%) | $59.00 K(+39.5%) | $38.30 K(-156.7%) |
| Nov 2006 | - | $42.30 K(+18.8%) | -$67.60 K(-5300.0%) |
| Aug 2006 | - | $35.60 K(-136.1%) | $1300.00(-103.4%) |
| May 2006 | - | -$98.60 K(+110.2%) | -$38.30 K(-22.5%) |
| Feb 2006 | -$9200.00(-96.7%) | -$46.90 K(-142.2%) | -$49.40 K(-68.4%) |
| Nov 2005 | - | $111.20 K(-2880.0%) | -$156.40 K(-56.6%) |
| Aug 2005 | - | -$4000.00(-96.4%) | -$360.60 K(-14.2%) |
| May 2005 | - | -$109.70 K(-28.7%) | -$420.20 K(+51.4%) |
| Feb 2005 | -$277.50 K(+68.1%) | -$153.90 K(+65.5%) | -$277.50 K(+39.7%) |
| Nov 2004 | - | -$93.00 K(+46.2%) | -$198.70 K(+30.7%) |
| Aug 2004 | - | -$63.60 K(-292.7%) | -$152.00 K(+14.8%) |
| May 2004 | - | $33.00 K(-143.9%) | -$132.40 K(-19.9%) |
| Feb 2004 | -$165.10 K(-3.5%) | -$75.10 K(+62.2%) | -$165.20 K(-26.1%) |
| Nov 2003 | - | -$46.30 K(+5.2%) | -$223.60 K(+17.1%) |
| Aug 2003 | - | -$44.00 K(<-9900.0%) | -$191.00 K(+37.4%) |
| May 2003 | - | $200.00(-100.1%) | -$139.00 K(-15.9%) |
| Feb 2003 | -$171.10 K(-40.9%) | -$133.50 K(+874.5%) | -$165.20 K(+38.9%) |
| Nov 2002 | - | -$13.70 K(-271.3%) | -$118.90 K(-33.8%) |
| Aug 2002 | - | $8000.00(-130.8%) | -$179.60 K(-21.4%) |
| May 2002 | - | -$26.00 K(-70.2%) | -$228.40 K(-21.1%) |
| Feb 2002 | -$289.40 K(+1563.2%) | -$87.20 K(+17.2%) | -$289.40 K(-4.6%) |
| Nov 2001 | - | -$74.40 K(+82.4%) | -$303.50 K(+36.0%) |
| Aug 2001 | - | -$40.80 K(-53.1%) | -$223.20 K(+64.4%) |
| May 2001 | - | -$87.00 K(-14.1%) | -$135.80 K(+680.5%) |
| Feb 2001 | -$17.40 K(-88.4%) | -$101.30 K(-1816.9%) | -$17.40 K(-120.7%) |
| Nov 2000 | - | $5900.00(-87.3%) | $83.90 K(+7.6%) |
| Aug 2000 | - | $46.60 K(+48.4%) | $78.00 K(+148.4%) |
| May 2000 | - | $31.40 K | $31.40 K |
| Feb 2000 | -$149.50 K | - | - |
FAQ
- What is KORU Medical Systems annual EBITDA?
- What is the all time high annual EBITDA for KORU Medical Systems?
- What is KORU Medical Systems annual EBITDA year-on-year change?
- What is KORU Medical Systems quarterly EBITDA?
- What is the all time high quarterly EBITDA for KORU Medical Systems?
- What is KORU Medical Systems quarterly EBITDA year-on-year change?
- What is KORU Medical Systems TTM EBITDA?
- What is the all time high TTM EBITDA for KORU Medical Systems?
- What is KORU Medical Systems TTM EBITDA year-on-year change?
What is KORU Medical Systems annual EBITDA?
The current annual EBITDA of KRMD is -$9.40 M
What is the all time high annual EBITDA for KORU Medical Systems?
KORU Medical Systems all-time high annual EBITDA is $4.34 M
What is KORU Medical Systems annual EBITDA year-on-year change?
Over the past year, KRMD annual EBITDA has changed by +$794.10 K (+7.79%)
What is KORU Medical Systems quarterly EBITDA?
The current quarterly EBITDA of KRMD is -$1.48 M
What is the all time high quarterly EBITDA for KORU Medical Systems?
KORU Medical Systems all-time high quarterly EBITDA is $1.77 M
What is KORU Medical Systems quarterly EBITDA year-on-year change?
Over the past year, KRMD quarterly EBITDA has changed by +$493.70 K (+25.07%)
What is KORU Medical Systems TTM EBITDA?
The current TTM EBITDA of KRMD is -$6.15 M
What is the all time high TTM EBITDA for KORU Medical Systems?
KORU Medical Systems all-time high TTM EBITDA is $4.55 M
What is KORU Medical Systems TTM EBITDA year-on-year change?
Over the past year, KRMD TTM EBITDA has changed by +$3.25 M (+34.58%)